Earnings History Data for Coherus BioSciences, Inc. (CHRS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Coherus BioSciences, Inc.

Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics. Its clinical stage pipeline consists of CHS-0214 in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420 that has completed a Phase I study to treat psoriasis or rheumatoid arthritis; and CHS-1701 which has completed a Phase I study for the treatment of breast cancer patients. Coherus Biosciences, Inc. is headquartered in Redwood City, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
08-11-2022 AH 4:00 PM ET
(Nov 8)		 CHRS Coherus BioSciences, Inc. 621.80 -1.11 -0.79 -0.49 Coherus BioSciences Non-GAAP EPS of -$0.96 misses by $0.32, revenue of $45.42M misses by $10.94M
[11/8/2022 4:39 PM]		 6.93 -1.05 
(-13.20%)		 7.99 0.0 
(0.00%)		 5.60 - 19.32 2,521,215 930,000 20,316
04-08-2022 AH 4:00 PM ET
(Aug 4)		 CHRS Coherus BioSciences, Inc. 555.12 -0.65 -0.96 -0.40 Coherus BioSciences GAAP EPS of -$0.65 beats by $0.21, revenue of $60.2M misses by $1.24M
[8/4/2022 4:05 PM]		 11.84 1.26 
(11.91%)		 10.50 -0.08 
(-0.76%)		 5.60 - 19.32 1,506,545 1,210,000 303
05-05-2022 AH 4:00 PM ET
(May 5)		 CHRS Coherus BioSciences, Inc. 748.55 -1.24 -0.80 -2.37 Coherus BioSciences Non-GAAP EPS of -$1.00 misses by $0.35, revenue of $60.12M misses by $10.42M
[5/5/2022 4:28 PM]		 8.44 -0.38 
(-4.37%)		 8.90 0.08 
(0.91%)		 8.41 - 19.32 937,928 920,000 245
17-02-2022 AH 4:00 PM ET
(Feb 17)		 CHRS Coherus BioSciences, Inc. 1,000.00 -0.60 -0.61 0.12 Coherus BioSciences Non-GAAP EPS of -$0.46 beats by $0.08, revenue of $73.37M misses by $9.24M
[2/17/2022 4:06 PM]		 12.33 -0.52 
(-4.05%)		 12.85 0.0 
(0.00%)		 11.13 - 19.32 1,012,201 1,130,000 16,370
08-11-2021 AH 4:00 PM ET
(Nov 8)		 CHRS Coherus BioSciences, Inc. 1,350 -0.49 -0.40 0.33 Coherus BioSciences EPS misses by $0.05, misses on revenue
[11/8/2021 4:04 PM]		 18.70 1.19 
(6.80%)		 17.51 0.0 
(0.00%)		 12.21 - 22.22 1,232,910 620,000 35,116
05-08-2021 AH 4:00 PM ET
(Aug 5)		 CHRS Coherus BioSciences, Inc. 988.57 -0.40 -0.25 0.70 Coherus BioSciences EPS misses by $0.21, beats on revenue
[8/5/2021 4:10 PM]		 13.05 0.09 
(0.69%)		 12.96 0.0 
(0.00%)		 12.21 - 22.22 912,888 520,000 28,923
06-05-2021 AH 4:00 PM ET
(May 6)		 CHRS Coherus BioSciences, Inc. 1,110 -2.37 0.09 0.54 Coherus BioSciences EPS misses by $0.10, misses on revenue
[5/6/2021 4:19 PM]		 14.35 -0.15 
(-1.03%)		 14.00 -0.50 
(-3.45%)		 13.53 - 22.22 753,762 770,000 146
24-02-2021 AH 4:00 PM ET
(Feb 24)		 CHRS Coherus BioSciences, Inc. 1,240 0.12 0.25 0.53 Coherus BioSciences EPS misses by $0.04, misses on revenue
[2/24/2021 4:36 PM]		 15.28 -0.94 
(-5.82%)		 16.00 -0.23 
(-1.42%)		 10.86 - 22.22 2,047,353 1,085,081 1,829
05-11-2020 AH 4:00 PM ET
(Nov 5)		 CHRS Coherus BioSciences, Inc. 1,220 0.33 0.34 0.63 Coherus BioSciences EPS beats by $0.13, misses on revenue, revised FY20 outlook
[11/5/2020 4:45 PM]		 16.66 -1.62 
(-8.86%)		 16.60 -1.68 
(-9.19%)		 10.86 - 23.03 1,477,146 887,242 51,881
06-08-2020 AH 4:10 PM ET
(Aug 6)		 CHRS Coherus BioSciences, Inc. 1,290 0.70 0.26 0.32 Coherus BioSciences EPS beats by $0.52, beats on revenue
[8/6/2020 4:22 PM]		 20.22 2.81 
(16.14%)		 19.70 2.29 
(13.15%)		 10.86 - 23.91 2,023,571 879,866 5,978